DALLA-FAVERA; Riccardo

Patent Applications and Registrations

Patent applications and USPTO patent grants for DALLA-FAVERA; Riccardo.The latest application filed is for "tissue-specific micrornas and compositions and uses thereof".

Company Profile

0.9.9

DALLA-FAVERA; Riccardo - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tissue-specific Micrornas And Compositions And Uses Thereof App 20140171484 - CALIFANO; Andrea ; et al.	2014-06-19
Tissue-specific MicroRNAs and compositions and uses thereof Grant 8,586,726 - Califano , et al. November 19, 2	2013-11-19
Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma Grant 8,299,220 - Dalla-Favera October 30, 2	2012-10-30
Isolation Of Five Novel Genes Coding For New Fc Receoptrs-type Melanoma Involved In The Pathogenesis Of Lymphoma/melanoma App 20110110951 - Dalla-Favera; Riccardo	2011-05-12
Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma Grant 7,863,424 - Dalla-Favera January 4, 2	2011-01-04
Tissue-Specific MicroRNAs and Compositions and Uses Thereof App 20100197772 - Califano; Andrea ; et al.	2010-08-05
Systems And Methods For Identifying Combinations Of Compounds Of Therapeutic Interest App 20090269772 - Califano; Andrea ; et al.	2009-10-29
Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia App 20080280297 - Dalla-Favera; Riccardo	2008-11-13
Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma App 20070148176 - Dalla-Favera; Riccardo	2007-06-28
MUM-1 protein expressed by multiple myeloma-related gene App 20070141579 - Dalla-Favera; Riccardo	2007-06-21
Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/myeloma Grant 7,105,149 - Dalla-Favera September 12, 2	2006-09-12
MUM-1 protein expressed by multiple myeloma-related gene Grant 6,958,386 - Dalla-Favera October 25, 2	2005-10-25
Cloning and uses of the genetic locus bcl-6 Grant 6,783,945 - Chaganti , et al. August 31, 2	2004-08-31
Cloning and uses of the genetic locus bcl-6 App 20010012887 - Chaganti, Raju S.K. ; et al.	2001-08-09
Cloning And Uses Of The Genetic Locus Bcl-6 App 20010010922 - DALLA-FAVERA, RICCARDO ; et al.	2001-08-02
Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs Grant 6,268,138 - Dalla-Favera , et al. July 31, 2	2001-07-31
Cloning and uses of the genetic locus BCL-6 Grant 5,882,858 - Dalla-Favera , et al. March 16, 1	1999-03-16

Company Registrations

NCAGE Code	4RVN2	DALLA-FAVERA RICCARDO
CAGE Code	4RVN2	DALLA-FAVERA, RICCARDO
SEC	0001332762	Dalla-Favera Riccardo

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.